ALB Albemarle Corporation

Q1 2025 10-Q

Filed: Apr 30, 2025Period ending Mar 31, 2025

Health Care

Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR

Albemarle Corporation (ALB) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 30, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Risk Factors

• No new or changed risk factors disclosed this quarter vs most recent 10-K
• Carried-forward regulatory risk: compliance with environmental and chemical industry regulations impacting operations

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.1B

▼ -20.9% YoY

Net Income

$41M

▲ +1589.1% YoY

Gross Margin

14.5%

▲ +1165bp YoY

Operating Margin

1.8%

▲ +1503bp YoY

Net Margin

3.8%

▲ +366bp YoY

EPS (Diluted)

$0.00

▲ +100.0% YoY

Operating Cash Flow

$545M

▲ +456.8% YoY

Source: XBRL data from Albemarle Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Albemarle Corporation Quarterly Reports

Q3 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Albemarle Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.